Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Colorectal Neoplasms

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    February 2020
  1. YEOH YK, Chen Z, Wong MCS, Hui M, et al
    Southern Chinese populations harbour non-nucleatum Fusobacteria possessing homologues of the colorectal cancer-associated FadA virulence factor.
    Gut. 2020 Feb 12. pii: gutjnl-2019-319635. doi: 10.1136/gutjnl-2019-319635.
    PubMed     Text format     Abstract available


  2. NG SC, Kyaw MH, Suen BY, Tse YK, et al
    Prospective colonoscopic study to investigate risk of colorectal neoplasms in first-degree relatives of patients with non-advanced adenomas.
    Gut. 2020;69:304-310.
    PubMed     Text format     Abstract available


    January 2020
  3. PICHLER M, Rodriguez-Aguayo C, Nam SY, Dragomir MP, et al
    Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.
    Gut. 2020 Jan 27. pii: gutjnl-2019-318903. doi: 10.1136/gutjnl-2019-318903.
    PubMed     Text format     Abstract available


  4. CROSS AJ, Robbins EC, Pack K, Stenson I, et al
    Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study.
    Gut. 2020 Jan 17. pii: gutjnl-2019-320036. doi: 10.1136/gutjnl-2019-320036.
    PubMed     Text format     Abstract available


  5. BLEIJENBERG AG, IJspeert JE, van Herwaarden YJ, Carballal S, et al
    Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study.
    Gut. 2020;69:112-121.
    PubMed     Text format     Abstract available


    December 2019
  6. MA W, Chan AT
    Antibiotic use and colorectal cancer: a causal association?
    Gut. 2019 Dec 24. pii: gutjnl-2019-319792. doi: 10.1136/gutjnl-2019-319792.
    PubMed     Text format    


  7. ZORZI M, Cavestro GM, Guzzinati S, Dal Maso L, et al
    Decline in the incidence of colorectal cancer and the associated mortality in young Italian adults.
    Gut. 2019 Dec 16. pii: gutjnl-2019-320406. doi: 10.1136/gutjnl-2019-320406.
    PubMed     Text format    


  8. MATHEW A, Baby B, Wang K, Sirohi B, et al
    Colorectal cancer incidence in younger adults in India.
    Gut. 2019 Dec 13. pii: gutjnl-2019-320271. doi: 10.1136/gutjnl-2019-320271.
    PubMed     Text format    


  9. MONTAZERI Z, Li X, Nyiraneza C, Ma X, et al
    Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer.
    Gut. 2019 Dec 9. pii: gutjnl-2019-319313. doi: 10.1136/gutjnl-2019-319313.
    PubMed     Text format     Abstract available


  10. DE BARRIOS O, Sanchez-Moral L, Cortes M, Ninfali C, et al
    ZEB1 promotes inflammation and progression towards inflammation-driven carcinoma through repression of the DNA repair glycosylase MPG in epithelial cells.
    Gut. 2019;68:2129-2141.
    PubMed     Text format     Abstract available


    November 2019
  11. REICHLING C, Taieb J, Derangere V, Klopfenstein Q, et al
    Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study.
    Gut. 2019 Nov 28. pii: gutjnl-2019-319292. doi: 10.1136/gutjnl-2019-319292.
    PubMed     Text format     Abstract available


  12. MONAHAN KJ, Bradshaw N, Dolwani S, Desouza B, et al
    Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).
    Gut. 2019 Nov 28. pii: gutjnl-2019-319915. doi: 10.1136/gutjnl-2019-319915.
    PubMed     Text format     Abstract available


  13. RUTTER MD, East J, Rees CJ, Cripps N, et al
    British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines.
    Gut. 2019 Nov 27. pii: gutjnl-2019-319858. doi: 10.1136/gutjnl-2019-319858.
    PubMed     Text format     Abstract available


    October 2019
  14. KUIPERS EJ, Grobbee EJ
    Personalised screening for colorectal cancer, ready for take-off.
    Gut. 2019 Oct 15. pii: gutjnl-2019-319677. doi: 10.1136/gutjnl-2019-319677.
    PubMed     Text format    


  15. WANG P, Berzin TM, Glissen Brown JR, Bharadwaj S, et al
    Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study.
    Gut. 2019;68:1813-1819.
    PubMed     Text format     Abstract available


    September 2019
  16. KLEEMAN SO, Koelzer VH, Jones HJ, Vazquez EG, et al
    Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification.
    Gut. 2019 Sep 28. pii: gutjnl-2019-319126. doi: 10.1136/gutjnl-2019-319126.
    PubMed     Text format     Abstract available


  17. SIEGEL RL, Torre LA, Soerjomataram I, Hayes RB, et al
    Global patterns and trends in colorectal cancer incidence in young adults.
    Gut. 2019 Sep 5. pii: gutjnl-2019-319511. doi: 10.1136/gutjnl-2019-319511.
    PubMed     Text format     Abstract available


  18. SCOTT AJ, Alexander JL, Merrifield CA, Cunningham D, et al
    International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis.
    Gut. 2019;68:1624-1632.
    PubMed     Text format     Abstract available


  19. KANDEL P, Brand EC, Pelt J, Ball CT, et al
    Endoscopic scar assessment after colorectal endoscopic mucosal resection scars: when is biopsy necessary (EMR Scar Assessment Project for Endoscope (ESCAPE) trial).
    Gut. 2019;68:1633-1641.
    PubMed     Text format     Abstract available


  20. CROSS AJ, Wooldrage K, Robbins EC, Kralj-Hans I, et al
    Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study.
    Gut. 2019;68:1642-1652.
    PubMed     Text format     Abstract available


    August 2019
  21. ZHANG J, Haines C, Watson AJM, Hart AR, et al
    Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study.
    Gut. 2019 Aug 19. pii: gutjnl-2019-318593. doi: 10.1136/gutjnl-2019-318593.
    PubMed     Text format     Abstract available


    July 2019
  22. WEI T, Luo P, Zhang X, Zhu W, et al
    Comparison of the incidence of colorectal cancer in young adults between the USA and Europe.
    Gut. 2019 Jul 31. pii: gutjnl-2019-319391. doi: 10.1136/gutjnl-2019-319391.
    PubMed     Text format    


  23. REN J, Yao M
    Cautious view on the link between yoghurt consumption and risk of colorectal cancer.
    Gut. 2019 Jul 29. pii: gutjnl-2019-319430. doi: 10.1136/gutjnl-2019-319430.
    PubMed     Text format    


  24. DE VRIES NL, van Unen V, Ijsselsteijn ME, Abdelaal T, et al
    High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity.
    Gut. 2019 Jul 3. pii: gutjnl-2019-318672. doi: 10.1136/gutjnl-2019-318672.
    PubMed     Text format     Abstract available


    June 2019
  25. ZHENG X, Wu K, Song M, Ogino S, et al
    Yogurt consumption and risk of conventional and serrated precursors of colorectal cancer.
    Gut. 2019 Jun 17. pii: gutjnl-2019-318374. doi: 10.1136/gutjnl-2019-318374.
    PubMed     Text format    


  26. BAHIN FF, Heitman SJ, Bourke MJ
    Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis.
    Gut. 2019;68:1130.
    PubMed     Text format    


    May 2019
  27. DOHAN A, Gallix B, Guiu B, Le Malicot K, et al
    Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
    Gut. 2019 May 17. pii: gutjnl-2018-316407. doi: 10.1136/gutjnl-2018-316407.
    PubMed     Text format     Abstract available


  28. VUIK FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, et al
    Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.
    Gut. 2019 May 16. pii: gutjnl-2018-317592. doi: 10.1136/gutjnl-2018-317592.
    PubMed     Text format     Abstract available


    April 2019
  29. ZORZI M, Zappa M
    Synthetic indicator of the impact of colorectal cancer screening programmes on incidence rates.
    Gut. 2019 Apr 30. pii: gutjnl-2019-318589. doi: 10.1136/gutjnl-2019-318589.
    PubMed     Text format     Abstract available


  30. VAUGHAN-SHAW PG, Zgaga L, Ooi LY, Theodoratou E, et al
    Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response.
    Gut. 2019 Apr 25. pii: gutjnl-2018-317922. doi: 10.1136/gutjnl-2018-317922.
    PubMed     Text format     Abstract available


  31. LANNAGAN TRM, Lee YK, Wang T, Roper J, et al
    Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.
    Gut. 2019;68:684-692.
    PubMed     Text format     Abstract available


  32. TIE J, Cohen JD, Wang Y, Li L, et al
    Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.
    Gut. 2019;68:663-671.
    PubMed     Text format     Abstract available


    February 2019
  33. CHEUNG KS, Chen L, Chan EW, Seto WK, et al
    Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients.
    Gut. 2019 Feb 26. pii: gutjnl-2018-317714. doi: 10.1136/gutjnl-2018-317714.
    PubMed     Text format     Abstract available


  34. HE Z, Gharaibeh RZ, Newsome RC, Pope JL, et al
    Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin.
    Gut. 2019;68:289-300.
    PubMed     Text format     Abstract available


  35. NGU WS, Bevan R, Tsiamoulos ZP, Bassett P, et al
    Improved adenoma detection with Endocuff Vision: the ADENOMA randomised controlled trial.
    Gut. 2019;68:280-288.
    PubMed     Text format     Abstract available


    January 2019
  36. LOPEZ A, Bouvier AM, Jooste V, Cottet V, et al
    Outcomes following polypectomy for malignant colorectal polyps are similar to those following surgery in the general population.
    Gut. 2019;68:111-117.
    PubMed     Text format     Abstract available


    December 2018
  37. STJARNGRIM J, Ekbom A, Hammar U, Hultcrantz R, et al
    Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
    Gut. 2018 Dec 15. pii: gutjnl-2018-316651. doi: 10.1136/gutjnl-2018-316651.
    PubMed     Text format     Abstract available


  38. SENORE C, Basu P, Anttila A, Ponti A, et al
    Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report.
    Gut. 2018 Dec 10. pii: gutjnl-2018-317293. doi: 10.1136/gutjnl-2018-317293.
    PubMed     Text format     Abstract available


  39. LADABAUM U
    Occult blood in faeces: a window into health beyond the colorectum?
    Gut. 2018;67:2079-2080.
    PubMed     Text format    


    November 2018
  40. COKER OO, Nakatsu G, Dai RZ, Wu WKK, et al
    Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
    Gut. 2018 Nov 24. pii: gutjnl-2018-317178. doi: 10.1136/gutjnl-2018-317178.
    PubMed     Text format     Abstract available


  41. BAHIN FF, Heitman SJ, Rasouli KN, Mahajan H, et al
    Wide-field endoscopic mucosal resection versus endoscopic submucosal dissection for laterally spreading colorectal lesions: a cost-effectiveness analysis.
    Gut. 2018;67:1965-1973.
    PubMed     Text format     Abstract available


  42. BUGAJSKI M, Wieszczy P, Hoff G, Rupinski M, et al
    Modifiable factors associated with patient-reported pain during and after screening colonoscopy.
    Gut. 2018;67:1958-1964.
    PubMed     Text format     Abstract available


    October 2018
  43. CHEN H, Li N, Ren J, Feng X, et al
    Participation and yield of a population-based colorectal cancer screening programme in China.
    Gut. 2018 Oct 30. pii: gutjnl-2018-317124. doi: 10.1136/gutjnl-2018-317124.
    PubMed     Text format     Abstract available


  44. DEKKER E, IJspeert JEG
    Serrated pathway: a paradigm shift in CRC prevention.
    Gut. 2018;67:1751-1752.
    PubMed     Text format    


  45. GERNER RR, Klepsch V, Macheiner S, Arnhard K, et al
    NAD metabolism fuels human and mouse intestinal inflammation.
    Gut. 2018;67:1813-1823.
    PubMed     Text format     Abstract available


    September 2018
  46. GUDRA D, Shoaie S, Fridmanis D, Klovins J, et al
    A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies.
    Gut. 2018 Sep 21. pii: gutjnl-2018-316225. doi: 10.1136/gutjnl-2018-316225.
    PubMed     Text format    


  47. TOES-ZOUTENDIJK E, Kooyker AI, Elferink MA, Spaander MCW, et al
    Stage distribution of screen-detected colorectal cancers in the Netherlands.
    Gut. 2018;67:1745-1746.
    PubMed     Text format    


  48. TOYOSHIMA O, Hata K, Yoshida S, Arita M, et al
    New-generation chromoendoscopy may increase confidence in the DISCARD2 study.
    Gut. 2018;67:1742-1743.
    PubMed     Text format    


  49. MURPHY G, Cross AJ, Dawsey SM, Stanczyk FZ, et al
    Serum ghrelin is associated with risk of colorectal adenocarcinomas in the ATBC study.
    Gut. 2018;67:1646-1651.
    PubMed     Text format     Abstract available


    August 2018
  50. POHL H, Kaminski MF
    Mindful choice of endoscopic resection for large colorectal lesions.
    Gut. 2018;67:1374-1375.
    PubMed     Text format    


  51. FUCCIO L, Repici A, Hassan C, Ponchon T, et al
    Why attempt en bloc resection of non-pedunculated colorectal adenomas? A systematic review of the prevalence of superficial submucosal invasive cancer after endoscopic submucosal dissection.
    Gut. 2018;67:1464-1474.
    PubMed     Text format     Abstract available


    July 2018
  52. LIBBY G, Fraser CG, Carey FA, Brewster DH, et al
    Occult blood in faeces is associated with all-cause and non-colorectal cancer mortality.
    Gut. 2018 Jul 16. pii: gutjnl-2018-316483. doi: 10.1136/gutjnl-2018-316483.
    PubMed     Text format     Abstract available


  53. BAKER AM, Cross W, Curtius K, Al Bakir I, et al
    Evolutionary history of human colitis-associated colorectal cancer.
    Gut. 2018 Jul 10. pii: gutjnl-2018-316191. doi: 10.1136/gutjnl-2018-316191.
    PubMed     Text format     Abstract available


  54. CHANG WL, Jackson C, Riel S, Cooper HS, et al
    Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas.
    Gut. 2018;67:1290-1298.
    PubMed     Text format     Abstract available


    June 2018
  55. KOMIYA Y, Shimomura Y, Higurashi T, Sugi Y, et al
    Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity.
    Gut. 2018 Jun 22. pii: gutjnl-2018-316661. doi: 10.1136/gutjnl-2018-316661.
    PubMed     Text format    


  56. WIETEN E, Schreuders EH, Grobbee EJ, Nieboer D, et al
    Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 22. pii: gutjnl-2017-315340. doi: 10.1136/gutjnl-2017-315340.
    PubMed     Text format     Abstract available


  57. NIEUWENBURG SAV, Vuik FER, Kruip MJHA, Kuipers EJ, et al
    Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis.
    Gut. 2018 Jun 5. pii: gutjnl-2018-316344. doi: 10.1136/gutjnl-2018-316344.
    PubMed     Text format     Abstract available


    May 2018
  58. GLUCK N, Half EE, Bieber V, Schwartz D, et al
    Novel prep-less X-ray imaging capsule for colon cancer screening: a feasibility study.
    Gut. 2018 May 21. pii: gutjnl-2018-316127. doi: 10.1136/gutjnl-2018-316127.
    PubMed     Text format    


  59. TEN HOVE JR, Shah SC, Shaffer SR, Bernstein CN, et al
    Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study.
    Gut. 2018 May 2. pii: gutjnl-2017-315440. doi: 10.1136/gutjnl-2017-315440.
    PubMed     Text format     Abstract available


  60. BARENDSE RM, Musters GD, de Graaf EJR, van den Broek FJC, et al
    Randomised controlled trial of transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND Study).
    Gut. 2018;67:837-846.
    PubMed     Text format     Abstract available


    April 2018
  61. KONG F, Li L, Wang G, Deng X, et al
    VDR signaling inhibits cancer-associated-fibroblasts' release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells.
    Gut. 2018 Apr 25. pii: gutjnl-2018-316627. doi: 10.1136/gutjnl-2018-316627.
    PubMed     Text format    


  62. SMITH T, Muller DC, Moons KGM, Cross AJ, et al
    Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies.
    Gut. 2018 Apr 3. pii: gutjnl-2017-315730. doi: 10.1136/gutjnl-2017-315730.
    PubMed     Text format     Abstract available


  63. CAO Y, Wu K, Mehta R, Drew DA, et al
    Long-term use of antibiotics and risk of colorectal adenoma.
    Gut. 2018;67:672-678.
    PubMed     Text format     Abstract available


  64. MOUSSATA D, Allez M, Cazals-Hatem D, Treton X, et al
    Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
    Gut. 2018;67:616-624.
    PubMed     Text format     Abstract available


  65. BATTERSBY NJ, Bouliotis G, Emmertsen KJ, Juul T, et al
    Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score.
    Gut. 2018;67:688-696.
    PubMed     Text format     Abstract available


    March 2018
  66. JOO JE, Jayasekara H, Wong EM, Clendenning M, et al
    Assessing the ProMCol classifier as a prognostic marker for non-metastatic colorectal cancer within the Melbourne Collaborative Cohort Study.
    Gut. 2018 Mar 24. pii: gutjnl-2018-316122. doi: 10.1136/gutjnl-2018-316122.
    PubMed     Text format    


  67. RIGTER LS, Snaebjornsson P, Rosenberg EH, Atmodimedjo PN, et al
    Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Gut. 2018;67:447-455.
    PubMed     Text format     Abstract available


  68. DAVENPORT JR, Su T, Zhao Z, Coleman HG, et al
    Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps.
    Gut. 2018;67:456-465.
    PubMed     Text format     Abstract available


    February 2018
  69. SUNDKVIST A, Myte R, Palmqvist R, Harlid S, et al
    Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer.
    Gut. 2018 Feb 28. pii: gutjnl-2018-316110. doi: 10.1136/gutjnl-2018-316110.
    PubMed     Text format    


  70. CREMONESI E, Governa V, Garzon JFG, Mele V, et al
    Gut microbiota modulate T cell trafficking into human colorectal cancer.
    Gut. 2018 Feb 6. pii: gutjnl-2016-313498. doi: 10.1136/gutjnl-2016-313498.
    PubMed     Text format     Abstract available


  71. OVERWATER A, Kessels K, Elias SG, Backes Y, et al
    Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes.
    Gut. 2018;67:284-290.
    PubMed     Text format     Abstract available


  72. RICHARDS CH, Ventham NT, Mansouri D, Wilson M, et al
    An evidence-based treatment algorithm for colorectal polyp cancers: results from the Scottish Screen-detected Polyp Cancer Study (SSPoCS).
    Gut. 2018;67:299-306.
    PubMed     Text format     Abstract available


    January 2018
  73. WILLIAMS DS, Mouradov D, Jorissen RN, Newman MR, et al
    Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315664. doi: 10.1136/gutjnl-2017-315664.
    PubMed     Text format     Abstract available


  74. DE ARCANGELIS A, Chamaillard M, Simon-Assmann P, Labouesse M, et al
    Integrin a6 loss promotes colitis-associated colorectal cancer. Response to: "Integrin a6 variants and colorectal cancer" by Beaulieu JF.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315727. doi: 10.1136/gutjnl-2017-315727.
    PubMed     Text format    


  75. BACKES Y, Schwartz MP, Ter Borg F, Wolfhagen FHJ, et al
    Multicentre prospective evaluation of real-time optical diagnosis of T1 colorectal cancer in large non-pedunculated colorectal polyps using narrow band imaging (the OPTICAL study).
    Gut. 2018 Jan 3. pii: gutjnl-2017-314723. doi: 10.1136/gutjnl-2017-314723.
    PubMed     Text format     Abstract available


  76. LAWLER M, Alsina D, Adams RA, Anderson AS, et al
    Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
    Gut. 2018;67:179-193.
    PubMed     Text format     Abstract available


  77. CARBALLAL S, Maisterra S, Lopez-Serrano A, Gimeno-Garcia AZ, et al
    Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
    Gut. 2018;67:70-78.
    PubMed     Text format     Abstract available


    December 2017
  78. DEMING DA
    Tailoring the colorectal cancer disease assessment to the treatment strategy.
    Gut. 2017 Dec 21. pii: gutjnl-2017-315394. doi: 10.1136/gutjnl-2017-315394.
    PubMed     Text format    


  79. SIEVERS CK, Zou LS, Pickhardt PJ, Matkowskyj KA, et al
    Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates.
    Gut. 2017;66:2132-2140.
    PubMed     Text format     Abstract available


    November 2017
  80. WAN L, Yu W, Shen E, Sun W, et al
    SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
    Gut. 2017 Nov 7. pii: gutjnl-2017-314983. doi: 10.1136/gutjnl-2017-314983.
    PubMed     Text format     Abstract available


  81. GUNDERT M, Edelmann D, Benner A, Jansen L, et al
    Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
    Gut. 2017 Nov 3. pii: gutjnl-2017-314711. doi: 10.1136/gutjnl-2017-314711.
    PubMed     Text format     Abstract available


  82. ZORZI M, Hassan C, Capodaglio G, Fedato C, et al
    Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test.
    Gut. 2017 Nov 3. pii: gutjnl-2017-314753. doi: 10.1136/gutjnl-2017-314753.
    PubMed     Text format     Abstract available


    October 2017
  83. MAZARD T, Boonsirikamchai P, Overman MJ, Asran MA, et al
    Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.
    Gut. 2017 Oct 30. pii: gutjnl-2017-313786. doi: 10.1136/gutjnl-2017-313786.
    PubMed     Text format     Abstract available


  84. BEAULIEU JF
    Integrin alpha6 variants and colorectal cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315415. doi: 10.1136/gutjnl-2017-315415.
    PubMed     Text format    


  85. SCHRAMM C, Janhsen K, Demir M, Nierhoff D, et al
    Serrated polyposis syndrome may go undiagnosed even in structured colorectal cancer screening programmes performed by endoscopists with otherwise good quality indices.
    Gut. 2017 Oct 21. pii: gutjnl-2017-315321. doi: 10.1136/gutjnl-2017-315321.
    PubMed     Text format    


  86. FLEMER B, Warren RD, Barrett MP, Cisek K, et al
    The oral microbiota in colorectal cancer is distinctive and predictive.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314814. doi: 10.1136/gutjnl-2017-314814.
    PubMed     Text format     Abstract available


  87. BARAULT L, Amatu A, Siravegna G, Ponzetti A, et al
    Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Gut. 2017 Oct 5. pii: gutjnl-2016-313372. doi: 10.1136/gutjnl-2016-313372.
    PubMed     Text format     Abstract available


    August 2017
  88. ROBERTS SK
    Train-the-trainer education and colonoscopy quality indicators: where to now?
    Gut. 2017;66:1533-1534.
    PubMed     Text format    


    June 2017
  89. BUCHANAN DD, Clendenning M, Zhuoer L, Stewart JR, et al
    Lack of evidence for germline RNF43 mutations in patients with serrated polyposis syndrome from a large multinational study.
    Gut. 2017;66:1170-1172.
    PubMed     Text format    


    March 2016
  90. ADAMI HO, Bretthauer M, Emilsson L, Hernan MA, et al
    The continuing uncertainty about cancer risk in inflammatory bowel disease.
    Gut. 2016 Mar 23. pii: gutjnl-2015-311003. doi: 10.1136/gutjnl-2015-311003.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: